Tag: BrainCo

5 articles

Market Moves

Delian Capital partner warns of a Chinese BCI bubble

VCBeat, the Chinese healthcare-investment media outlet, published an on-record investor take on the Chinese brain-computer interface sector on 2 August 2026. Delian Capital partner Jiang Donghui framed the sector as at risk of a bubble cycle before maturity, laid out a four-quadrant investment matrix based on demand and technological advancement, and named Chinese BCI companies across invasive, semi-invasive and non-invasive paths. H1 2026 financing alone accounted for approximately 60 per cent of the sector's thirteen-year total.

Aug 2

Market Moves

BrainCo unveils a brain-to-robot developer platform at WAIC 2026 in Shanghai

On Friday 17 July 2026, at the World Artificial Intelligence Conference in Shanghai, BrainCo debuted its Brain-Controlled Robot AI Platform, a graphical developer toolkit that pairs its non-invasive EEG headset with third-party humanoid, robotic-arm, and quadruped robots from Unitree, Realman, and Deep Robotics. Nyx He, partner and senior vice president, framed the launch as the next chapter of human-machine collaboration. Live demonstrations at the booth showed a person in an EEG headband directing a robotic arm to pick up a cup and an apple without buttons, voice, or muscle movement.

Jul 18

Market Moves

CNBC profiles BrainCo as the Hangzhou non-invasive BCI leader runs up to its Hong Kong IPO

CNBC published a video interview by China reporter Elaine Yu with Nyx He, Partner and Senior Vice President at BrainCo, on 10 July 2026. The interview lands six months after BrainCo confidentially filed for a Hong Kong Stock Exchange listing on 12 January 2026 with CICC and UBS Group AG as arrangers, and six months after the company closed a ¥2 billion (approximately US$286 million) financing round co-led by IDG Capital and Walden International on 8 January 2026. BrainCo is one of Hangzhou's Six Little Dragons alongside DeepSeek, Unitree Robotics, Game Science, DEEP Robotics, and Manycore Tech.

Jul 10

Market Moves

Neuracle, maker of the world's first approved invasive BCI, files for a Shanghai STAR Market IPO with RMB 2.5B target raise

Neuracle, maker of the world's first approved invasive BCI, had a RMB 2.5B Shanghai STAR Market IPO prospectus accepted on 11 June 2026, opening a two-horse race with BrainCo for first publicly listed pure-play BCI.

Jun 22

Market Moves

China's First BCI Unicorn Pivots Prosthetics Expertise Into Humanoid Robot Hands

BrainCo's new Revo 3 dexterous hand applies neural decoding and tactile sensing from prosthetic limbs to humanoid robotics, backed by a US$286 million funding round.

Apr 13

Stay Ahead of the Curve

Get the latest BCI news, breakthroughs, and market moves delivered to your inbox.

No spam. One-click unsubscribe. We respect your privacy.